Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I
about
Clinical MRI of acute ischemic strokeRevascularization grading in endovascular acute ischemic stroke therapyRecommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement.Intra-arterial versus intra-venous thrombolysis within and after the first 3 hours of stroke onsetEquipoise among recanalization strategies.Endovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional NeurologyMechanical thrombectomy in acute ischemic stroke-experience from 6 years of practice.Imaging and treatment of patients with acute stroke: an evidence-based review.Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic strokeIncomplete mechanical recanalization of middle cerebral artery occlusions facilitates endogenous recanalization within 5 h.Revascularization results in the Interventional Management of Stroke II trial.Methodology of the Interventional Management of Stroke III Trial.A novel mechanical thrombectomy device for retrieval of intravascular thrombusThrombolytic treatment for in-hospital ischemic strokes in United States.CT and MRI early vessel signs reflect clot composition in acute strokeMachine learning for outcome prediction of acute ischemic stroke post intra-arterial therapy.Acute endovascular reperfusion therapy in ischemic stroke: a systematic review and meta-analysis of randomized controlled trials.Large deep white matter lesions may predict futile recanalization in endovascular therapy for acute ischemic strokeEndovascular revascularization for basilar artery occlusionAdvances in stroke therapySimultaneous combined intravenous recombinant tissue plasminogen activator and endovascular therapy for hyperacute middle cerebral artery m1 occlusion.Comparative Analysis of Endovascular Stroke Therapy Using Urokinase, Penumbra System and Retrievable (Solitare) Stent.Thrombus branching and vessel curvature are important determinants of middle cerebral artery trunk recanalization with Merci thrombectomy devices.Use of the New Solitaire (TM) AB Device for Mechanical Thrombectomy when Merci Clot Retriever Has Failed to Remove the Clot. A Case ReportCorrelation of middle cerebral artery tortuosity with successful recanalization using the Merci retrieval system with or without adjunctive treatments.Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion.Predictors of subarachnoid hemorrhage in acute ischemic stroke with endovascular therapyNational trends in utilization and outcomes of endovascular treatment of acute ischemic stroke patients in the mechanical thrombectomy era.Stent-based thrombectomy versus intravenous tissue plasminogen activator in acute ischaemic stroke: A systematic review and meta-analysis.Mechanical thrombectomy devices for endovascular management of acute ischemic stroke: Duke stroke center experienceTissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.Intravenous rt-PA: a tenth anniversary reflectionReperfusion activates metalloproteinases that contribute to neurovascular injuryMechanical reperfusion is associated with post-ischemic hemorrhage in rat brain.Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic stroke.Thrombus burden is associated with clinical outcome after intra-arterial therapy for acute ischemic stroke.Retrievable stent thrombectomy in the treatment of acute ischemic stroke: analysis of a revolutionizing treatment technique.Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography.Good clinical outcome after ischemic stroke with successful revascularization is time-dependent.Endovascular therapy in hyperacute ischaemic stroke: history and current status.
P2860
Q26865572-0149C1EC-3C81-4056-BCBE-DF09E70170FBQ27026934-2DBE6338-7005-4641-BC31-C0D1CDF1B36FQ30410761-3F3FAF99-525F-4D93-9F58-F7B753F6802AQ30470195-AAC091DD-FE36-4BAE-8FB0-B98634F9A9C0Q33547270-D252F9E0-BC90-44C9-A575-F36E33E25F3DQ33735191-72B2411C-5E4B-4F46-8405-543E44FBB2A5Q33804902-D79B58D2-8208-4225-8728-AEED4E3CCF59Q33926874-B8D10483-AACD-4AB9-9683-ED936E4DB0E5Q34067208-BC276764-2B23-4B66-A84D-CDC89155D1C9Q34143627-BCC8A000-3D53-494F-AFC1-3D6DD29A2621Q34666805-71352DF9-3829-46C2-A70A-BE45C8EB724DQ34672825-BD57E0D1-16D3-4274-9688-F8D3E9070801Q34679966-713FA6BE-7414-43B8-B1E8-D7D3FCC5C945Q34795101-B4A0F66E-A66D-45C9-8057-88B1277567FDQ34982195-902DB498-BE89-4E17-85B2-F48E35290984Q35092725-D2284340-E9EA-4F75-BFA5-4670FD8F07DAQ35542086-AD0DA807-434B-4B1A-AD84-17163DF7C88DQ35621039-CE536C13-AEAE-4753-BD8C-3B9D561CA679Q35621052-ADE5976E-9738-4BAF-87DA-77DE8B52D373Q35632748-D10CE73E-EFB0-4CCB-96F6-C570DF926FC5Q35752498-9836F71C-BB1E-4BE0-A6DC-287E46388A4DQ35777806-EE9BB32E-4A44-4551-A4DC-00D40E676F51Q35784036-EE1AE33F-6E23-4567-A4DA-291FE416A69AQ35820524-9261487E-3FDC-4FDF-9E8D-5EB2BAA94832Q35869460-6CA16596-E258-44BC-AD42-6753510E280FQ36007470-BE3E369D-F140-4BE0-BA90-7284F68207FEQ36073466-57A61037-2923-4738-8E4D-0E1FE2AC4129Q36469160-37B491E8-B782-42BC-99D1-B4C98F36B914Q36590174-465442FC-153D-4FB4-8A5A-A224DD6AE762Q36732607-44CFD559-B499-4B65-95F5-D14C59F175F4Q36925788-262886BE-0B46-45C3-94A4-A068BB35A962Q36982822-560FB8BA-F031-479F-914A-F8D1C64E9279Q36986393-A3ED951D-BA5F-4098-BE51-703E90B399B7Q37137114-01E7CFA3-09C8-4E63-87D8-D8A5A28D102BQ37158942-24BD68BC-5769-4267-AFDD-50D835F1F3D8Q37178669-511D7285-09EC-41C7-957A-6F195CAA6F45Q37227703-1016D875-E3E7-4CB0-AB47-4370BA1D96F3Q37361387-BA1F39CB-4A04-4DD2-BA1E-49EDDAAEE375Q37368356-EB52A0BB-5347-48BD-942D-BF35C96249C5Q37518030-B5E8DC2B-2E47-40B9-BD84-6A8A17B9EE56
P2860
Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Safety of mechanical thrombect ...... Ischemia (MERCI) trial, part I
@ast
Safety of mechanical thrombect ...... Ischemia (MERCI) trial, part I
@en
Safety of mechanical thrombect ...... Ischemia (MERCI) trial, part I
@nl
type
label
Safety of mechanical thrombect ...... Ischemia (MERCI) trial, part I
@ast
Safety of mechanical thrombect ...... Ischemia (MERCI) trial, part I
@en
Safety of mechanical thrombect ...... Ischemia (MERCI) trial, part I
@nl
prefLabel
Safety of mechanical thrombect ...... Ischemia (MERCI) trial, part I
@ast
Safety of mechanical thrombect ...... Ischemia (MERCI) trial, part I
@en
Safety of mechanical thrombect ...... Ischemia (MERCI) trial, part I
@nl
P1476
Safety of mechanical thrombect ...... Ischemia (MERCI) trial, part I
@en
P2093
P304
P407
P577
2006-06-01T00:00:00Z